Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol

被引：0
|
作者：
Antonio Simone Laganà
Luisa Barbaro
Alfonsa Pizzo
机构：
[1] University of Messina,Department of Pediatric Gynecological, Microbiological and Biomedical Sciences
[2] Family Counseling Center (Obstetrics and Gynecology Section),undefined
来源：
Archives of Gynecology and Obstetrics | 2015年 / 291卷
关键词：
Polycystic Ovary Syndrome; D-Chiro-Inositol; Ovarian function; Metabolic factors;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1181 / 1186
页数：5
相关论文
共 50 条
  • [21] Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
    Tang, Thomas
    Lord, Jonathan M.
    Norman, Robert J.
    Yasmin, Ephia
    Balen, Adam H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):
  • [22] Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
    Jacopo Troisi
    Claudia Cinque
    Luigi Giugliano
    Steven Symes
    Sean Richards
    David Adair
    Pierpaolo Cavallo
    Laura Sarno
    Giovanni Scala
    Maria Caiazza
    Maurizio Guida
    Journal of Ovarian Research, 12
  • [23] Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
    Tang, Thomas
    Lord, Jonathan M.
    Norman, Robert J.
    Yasmin, Ephia
    Balen, Adam H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (01):
  • [24] Effects of D-chiro-inositol (INS-1) on insulin, glucose and spontaneous ovulation in obese women with polycystic ovary syndrome (PCOS)
    Nestler, JE
    Jakubowicz, DJ
    Reamer, P
    Gunn, RD
    Allan, G
    DIABETES, 1998, 47 : A91 - A91
  • [25] High dose of d-chiro-inositol improves oocyte quality in women with polycystic ovary syndrome undergoing ICSI: a randomized controlled trial
    Mendoza, Nicolas
    Galan, Maria Isabel
    Molina, Cristina
    Mendoza-Tesarik, Raquel
    Conde, Cristina
    Mazheika, Maryna
    Diaz-Ropero, Maria Paz
    Fonolla, Juristo
    Tesarik, Jan
    Olivares, Monica
    GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (05) : 398 - 401
  • [26] Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility
    Morley, Lara C.
    Tang, Thomas
    Yasmin, Ephia
    Norman, Robert J.
    Balen, Adam H.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (11):
  • [27] Metabolomic change due to combined treatment with myo-inositol, D-chiro-inositol and glucomannan in polycystic ovarian syndrome patients: a pilot study
    Troisi, Jacopo
    Cinque, Claudia
    Giugliano, Luigi
    Symes, Steven
    Richards, Sean
    Adair, David
    Cavallo, Pierpaolo
    Sarno, Laura
    Scala, Giovanni
    Caiazza, Maria
    Guida, Maurizio
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (1)
  • [28] The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
    Yang, Hyun
    Lee, Sang R.
    Jo, Seong Lae
    Kim, Ae-Hyang
    Kim, Eun-Ryoung
    Qu, Fan
    Hong, Eui-Ju
    Lee, Hye Won
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] The Improvement Effect of D-Chiro-Inositol and Ecklonia cava K. in the Rat Model of Polycystic Ovarian Syndrome
    Yang, Hyun
    Lee, Sang R.
    Jo, Seong Lae
    Kim, Ae-Hyang
    Kim, Eun-Ryoung
    Qu, Fan
    Hong, Eui-Ju
    Lee, Hye Won
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [30] Myo-inositol and D-chiro-inositol (40:1) reverse histological and functional features of polycystic ovary syndrome in a mouse model
    Bevilacqua, Arturo
    Dragotto, Jessica
    Giuliani, Alessandro
    Bizzarri, Mariano
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (06) : 9387 - 9398
12345